Hospitals held a 48.1% share of the negative pressure wound therapy market in 2025, reflecting their central role in managing complex wounds that require close monitoring, surgical support, and coordinated inpatient care. Hospital settings remain the primary point of treatment for severe trauma cases, post-operative wounds, and patients with multiple clinical risks, which sustains demand for negative pressure wound therapy systems that can be integrated into established wound management workflows. Their leadership is also reinforced through the concentration of trained clinicians and access to advanced care infrastructure needed for device-based wound treatment.

Home healthcare is the fastest-growing end-use segment in the negative pressure wound therapy market as care delivery continues shifting toward lower-acuity settings once patients are stabilized. Growth is being reinforced through the practical need to extend wound care beyond hospitals while reducing the burden of prolonged inpatient stays. Negative pressure wound therapy is gaining momentum in home healthcare because it aligns with ongoing wound management needs for patients who require continued treatment but not constant hospital supervision, making it a more suitable option than facility-based care for a growing portion of use cases.

Wound Type Segment Analysis: Chronic Wounds (Largest Segment) vs Acute Wounds (Fastest-Growing Segment)

Within the negative pressure wound therapy market, chronic wounds accounted for the largest share in 2025 due to their prolonged healing timelines and frequent need for structured, ongoing intervention. Demand remains concentrated in this segment because chronic wounds often require repeated assessment and extended therapy management, which makes negative pressure wound therapy a practical treatment approach in routine wound care protocols. Its leadership is underpinned by the persistent clinical burden associated with wounds that do not heal quickly and therefore generate recurring treatment demand over longer periods.

Acute wounds are emerging as the fastest-growing wound type segment in the negative pressure wound therapy market, influenced by broader use in post-surgical and injury-related cases where timely healing and complication control are critical. This segment is gaining traction because acute wound treatment pathways are often more protocol-driven and increasingly incorporate device-assisted wound management earlier in the care cycle. Compared with alternatives that rely on more conventional dressing approaches, negative pressure wound therapy is seeing stronger momentum in acute wounds where clinicians are focused on managing recovery efficiently and reducing disruption during the healing process.